We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · August 21, 2022

Outcomes and Prognostic Factors of Octogenarians With Primary CNS Lymphoma Treated With High-Dose Methotrexate

Leukemia and Lymphoma

 

Additional Info

Disclosure statements are available on the authors' profiles:

Leukemia and Lymphoma
Outcome and prognostic factors of very old patients with primary CNS lymphoma: a retrospective analysis of patients ≥80 years treated with high-dose methotrexate-based chemotherapy
Leukemia and Lymphoma 2022 Jul 20;[EPub Ahead of Print], S Seidel, T Kowalski, V Nilius-Eliliwi, R Schroers, U Schlegel

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Brain Cancer Center of Excellence

Visit our Brain Cancer Center of Excellence for additional, in-depth coverage.


Further Reading